Oncology bioanalysis: from biomarkers to drug discovery

Biomark Med. 2015;9(9):819-20. doi: 10.2217/bmm.15.54. Epub 2015 Sep 2.

Authors

Clementina Mesaros¹, Ian A Blair^{1

2}

Affiliations

¹ Penn SRP Center, Center of Excellence in Environmental Toxicology, Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA.
² Center for Cancer Pharmacology, University of Pennsylvania, Rm 854 BRB II/III, 421 Curie Blvd, Philadelphia PA, 19104, USA.

PMID: 26329020
DOI: 10.2217/bmm.15.54

No abstract available

Keywords: biomarkers; cancer; diagnostic; therapies; validation.

Publication types

Introductory Journal Article

MeSH terms

Biomarkers, Tumor / analysis*
Chemistry Techniques, Analytical*
Drug Discovery*
Humans

Substances

Biomarkers, Tumor

Grants and funding

P30 ES013508/ES/NIEHS NIH HHS/United States